Home
J B Chemicals & Pharmaceuticals Ltd EPS

J B Chemicals & Pharmaceuticals Ltd
NSE: JBCHEPHARM
EPS
Key Highlights
- The Earning per Share of J B Chemicals & Pharmaceuticals Ltd is ₹ 42.26 as of 18 Jun 25 .
- The earning per share of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 9.2 to ₹ 9.36 over 8 quarters. This represents a CAGR of 0.87% .
Historical Earning per Share of J B Chemicals & Pharmaceuticals Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of J B Chemicals & Pharmaceuticals Ltd
Company Fundamentals for J B Chemicals & Pharmaceuticals Ltd
Market Cap
26,824 Cr
EPS
42.3
P/E Ratio (TTM)
40.7
P/B Ratio (TTM)
7.8
Day’s High
1720.3
Day’s Low
1667.05
DTE
0.0
ROE
19.2
52 Week High
2029.0
52 Week Low
1303.0
ROCE
26.0
Market Price of J B Chemicals & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
18 Jun 2025 | 1718.9 |
17 Jun 2025 | 1725.95 |
16 Jun 2025 | 1734.85 |
13 Jun 2025 | 1732.05 |
12 Jun 2025 | 1745.1 |
11 Jun 2025 | 1717 |
10 Jun 2025 | 1666.55 |
09 Jun 2025 | 1676.75 |
06 Jun 2025 | 1703.35 |
05 Jun 2025 | 1697.4 |
SWOT Analysis Of J B Chemicals & Pharmaceuticals Ltd
BlinkX Score for J B Chemicals & Pharmaceuticals Ltd
Asset Value vs Market Value of J B Chemicals & Pharmaceuticals Ltd
Market Value
₹ 26,825
Asset Value
Value addition
16.8 X
₹ 1,511
* All values are in ₹ crores
Competitive Comparison of EPS
Company | Market Cap | EPS |
---|
J B Chemicals & Pharmaceuticals Ltd | 26824 | 42.26 |
Sun Pharmaceutical Industries Ltd | 395326 | 47.81 |
Divis Laboratories Ltd | 173562 | 82.53 |
Cipla Ltd | 121023 | 65.28 |
Dr Reddys Laboratories Ltd | 109551 | 67.77 |
Torrent Pharmaceuticals Ltd | 109200 | 56.97 |
Company | |
---|---|
J B Chemicals & Pharmaceuticals Ltd | 26824 |
Sun Pharmaceutical Industries Ltd | 395326 |
Divis Laboratories Ltd | 173562 |
Cipla Ltd | 121023 |
Dr Reddys Laboratories Ltd | 109551 |
Torrent Pharmaceuticals Ltd | 109200 |
Historical Market Cap of J B Chemicals & Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of J B Chemicals & Pharmaceuticals Ltd
Historical Revenue of J B Chemicals & Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of J B Chemicals & Pharmaceuticals Ltd
Historical EBITDA of J B Chemicals & Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of J B Chemicals & Pharmaceuticals Ltd
Historical Net Profit of J B Chemicals & Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of J B Chemicals & Pharmaceuticals Ltd
Dividend Payout Over Time
J B Chemicals & Pharmaceuticals Ltd News Hub
J B Chemicals & Pharmaceuticals Ltd soars 1.09%, Gains for third straight session
J B Chemicals & Pharmaceuticals Ltd is up for a third straight session in a row. The stock is quotin
Read more
14 Aug 24
J B Chemicals & Pharmaceuticals allots 11,500 equity shares under ESOS
J B Chemicals & Pharmaceuticals has allotted 11,500 equity shares under ESOS on 08 August 2024. Cons
Read more
08 Aug 24
J B Chemicals & Pharmaceuticals consolidated net profit rises 24.25% in the June 2024 quarter
Net profit of J B Chemicals & Pharmaceuticals rose 24.25% to Rs 176.83 crore in the quarter ended Ju
Read more
08 Aug 24
J B Chemicals & Pharmaceuticals allots 69,850 equity shares under ESOS
J B Chemicals & Pharmaceuticals has allotted 69,850 equity shares under ESOS on 26 August 2024. Cons
Read more
27 Aug 24